| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 12 |
| 1 | METOPROLOL | 11 |
| 2 | METOPROLOL TARTRATE | 11 |
| 3 | METOPROLOL TARTRATE INJECTION | 10 |
| 4 | METHOTREXATE SODIUM | 9 |
| 5 | SIMVASTATIN | 8 |
| 6 | CITALOPRAM | 7 |
| 7 | EVOLOCUMAB | 7 |
| 8 | PREDNISOLONE | 7 |
| 9 | PREDNISOLONE ORAL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 1 | 0.0011 |
| 1 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 2 | SELUMETINIB | 1 | 0.0006 |
| 3 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 4 | HYDROXYZINE PAMOATE | 2 | 0.0005 |
| 5 | PROTAMINE SULFATE | 1 | 0.0005 |
| 6 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 7 | AVATROMBOPAG MALEATE | 1 | 0.0004 |
| 8 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 9 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 18 |
| 1 | Corticosteroid [EPC] | 15 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 8 |
| 3 | PCSK9 Inhibitor [EPC] | 7 |
| 4 | Vitamin C [EPC] | 7 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 6 | Kinase Inhibitor [EPC] | 6 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 6 |
| 9 | Aromatase Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 2 | 0.0003 |
| 2 | PCSK9 Inhibitor [EPC] | 7 | 0.0003 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 4 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 4 | 0.0002 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 7 | Barbiturate [EPC] | 1 | 0.0001 |
| 8 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Androgen [EPC] | 2 | 0.0001 |